Speaking with musician and producer Adrian Quesada elicits a calming effect, as if a salve has been applied to the people ...

Adding Lp(a) to the PREVENT risk equations did not significantly improve risk prediction at the population level, but ...

The Jamaican dancehall superstar also revealed his all-time favorite artists in the genre. Read the Billboard interview.

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting hepa ...

LP Building Solutions released its 2025 Sustainability Report, which details the company’s continued emphasis on responsible ...

Lp(a) shares similarities with another lipoprotein that doctors target to reduce the risk of heart disease, known as low-density lipoprotein (LDL) – often referred to as “bad cholesterol ...

Experts discuss the current prevalence of lipoprotein(a) (Lp[a]) testing in the US, both in the general population and among those with established atherosclerotic cardiovascular disease (ASCVD ...

The Puerto Rican duo, made up Luis Alfredo Del Valle and Raquel Berrios, explored emotions and struggles to stay together on ...

Lp(a) is a liver-produced particle similar to LDL — “bad cholesterol” — that contributes to plaque buildup in arteries, significantly increasing the risk of heart attacks and strokes.

But lipoprotein(a) is more prone to plaque buildup and clots in the arteries than LDL, according to lead author Steven Nissen, M.D., chief academic officer of the Heart, Vascular & Thoracic ...

In the Phase 2 ALPACA study, lepodisiran significantly reduced Lp(a) levels by an average of 93.9% over the 60 to 180-day period after treatment with the highest tested dose (400 mg), meeting the ...

While many have not heard of Lipoprotein (a), or Lp (a), the biomarker is elevated in an estimated 20% of individuals ...